SBF NATUROPATHY LIMITEDActive

Company number 09574353Private limited companyIncorporated 2015

Key figures

£567-89.2%
Net assets 2024/25
+17.4%
Average annual growth 2019/20–2024/25
05 k10 k15 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, SBF NATUROPATHY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
025 k50 k75 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand39,03531,14529,27333,50112,328
Total assets62,69756,99959,47861,43748,166
Total liabilities48,11643,55047,39456,188—
Net assets / total equity14,58113,44912,0845,249567
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Alternative medicine

As described in the company's latest filed accounts.

Summary: SBF NATUROPATHY LIMITED

Company

SBF NATUROPATHY LIMITED is a private limited company registered with Companies House under company number 09574353. It was incorporated on 5 May 2015. Its status is active. The registered office is in Forest row (RH18). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Net assets were £567, down 89.2% on the previous year. Cash at bank and in hand was £12,328. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 19 May 2027.